Treatment of patients with acute schizophrenia using paliperidone extended-release tablets: A 6-week placebo-controlled study

被引：0
|
作者：
Kane, JM [1 ]
Kramer, M [1 ]
Ford, L [1 ]
Gassmann-Mayer, C [1 ]
Lim, P [1 ]
Eerdekens, M [1 ]
机构：
[1] Zucker Hillside Hosp, Dept Psychiat, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2005年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S191 / S192
页数：2
相关论文
共 50 条
  • [1] Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial
    Kane, J.
    Canas, F.
    Kramer, M.
    Ford, L.
    Gassmann-Mayer, C.
    Lim, P.
    Eerdekens, M.
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 147 - 161
  • [2] Patients with acute schizophrenia: Treatment with three fixed dosages of oral paliperidone extended-release tablets in a 6-week placebo-controlled study
    Kane, J
    Kramer, M
    Ford, L
    Gassmann-Mayer, C
    Lim, P
    Eerdekens, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 53 - 54
  • [3] Efficacy and tolerability of two fixed dosages of paliperidone extended-release tablets in the treatment of acute schizophrenia: A 6-week placebo-controlled study
    Marder, SR
    Kramer, M
    Ford, L
    Eerdekens, E
    Pilar, L
    Eerdekens, M
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S200 - S200
  • [4] Efficacy, safety and effect on functioning of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: An International 6-week placebo-controlled study
    Davidson, M
    Emsley, R
    Kramer, M
    Ford, L
    Gassmann-Mayer, C
    Lim, P
    Pan, J
    Eerdekens, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 43 - 43
  • [5] A 6-week placebo-controlled study of the safety and tolerability of flexible doses of oral paliperidone extended-release tablets in the treatment of schizophrenia in elderly patients
    Tzimos, A.
    Krainer, M.
    Ford, L.
    Gassmann-Mayer, C.
    Lim, P.
    Eerdekens, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S155 - S155
  • [6] A 6-week placebo-controlled study of the safety and tolerability of flexible doses of oral paliperidone extended-release tablets in the treatment of schizophrenia in elderly patients
    Tzimos, A.
    Kramer, M.
    McLemore, J.
    Ford, L.
    Gassmann-Mayer, C.
    Lim, P.
    Eerdekens, M.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 464 - 464
  • [7] Efficacy and safety of paliperidone extended-release tablets: Results of a 6-week, randomized, placebo-controlled study
    Marder, Stephen R.
    Kramer, Michelle
    Ford, Lisa
    Eerdekens, Els
    Lim, Pilar
    Eerdekens, Marielle
    Lowy, Adam
    BIOLOGICAL PSYCHIATRY, 2007, 62 (12) : 1363 - 1370
  • [8] Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: Pooled data from three 6-week placebo-controlled studies
    Meltzer, H.
    Kramer, M.
    Sherr, J.
    Gassmann-Mayer, C.
    Lim, P.
    Bobo, W.
    Eerdekens, M.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 447 - 447
  • [9] Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: Pooled data from three 6-week, placebo-controlled studies
    Meltzer, Herbert Y.
    Bobo, William V.
    Nuamah, Isaac F.
    Lane, Rosanne
    Hough, David
    Kramer, Michelle
    Eerdekens, Marielle
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (05) : 817 - 829
  • [10] A 6-week, US-based, placebo-controlled study on the efficacy and tolerability of two fixed dosages of oral paliperidone extended-release tablets in the treatment of acute schizophrenia
    Marder, SR
    Kramer, M
    Ford, L
    Eerdekens, E
    Lim, P
    Eerdekens, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 56 - 56
12345